Influence of the Type and Amount of Liver Resection on the Survival of the Patients with Colorectal Metastases

Authors

  • Stefan Petrovski Clinical Hospital Shtip, Surgery, Ljuben Ivanov bb, Shtip
  • Marija Karakolevska-Ilova Clinical Hospital Shtip, Oncology, Shtip
  • Elena Simeonovska-Joveva Clinical Hospital Shtip, Neurology, Shtip
  • Aleksandar Serafimov Clinical Hospital Shtip, Shtip
  • Ljubica Adzi-Andov Amedela Laboratory, Skopje
  • Violeta Dimitrova Clinic of General and Hepato-Pancreatic Surgery, University Hospital "Aleksandrovska", Sofia

DOI:

https://doi.org/10.3889/oamjms.2018.116

Keywords:

Life Style, Pregnancy, Stress, Psychological, Religion, Islam

Abstract

INTRODUCTION: Colorectal liver metastases have a poor prognosis, and only 2% have an average 5-year survival if left untreated. Despite radical resection, the average five-year survival is between 25% and 44%.

AIM: To explore the experience of the Clinic in the treatment of colorectal liver metastases, comparing it with data from the literature and based on the comparison to determine the influence of the type and extensity of resection survival after radical surgical treatment of patients.

METHODS: This is a retrospective study. The study comprised the period between 01.01.2006 to 31.12.2015. It included a total of 239 cases, of whom: 179 patients underwent radical interventions, 5 palliative and 55 patients underwent explorative interventions due to liver metastases.

RESULTS: Radical resection of liver metastases has the impact of the patient survival, and the survival is the smallest in the patients with left hemihepatectomy and the longest in the patients with bisegmentectomy. But no specific technique and the number of resected segments influenced the survival of patients with colorectal liver metastases.

CONCLUSION: In patients with colorectal liver metastases only resection has potentially curative character. The type and amount of liver resection has no influence of the survival.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Valeryanova Z, Dimitrova N, Vukov M, Atanasov T. Zabolyaemost ot rak v Blgaria, 2015.

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [online]. International Agency for Research on Cancer, Lyon (France), 2013. PMCid:PMC3865341

Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred fourty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000; 191:38-46. https://doi.org/10.1016/S1072-7515(00)00261-1

Bismuth H, Houssin D, Mazmanian G. Postoperative liver insufficiency: prevention and management. World J Surg. 1983; 7:505–510. https://doi.org/10.1007/BF01655941 PMid:6624126

Kandil E, Noureldine SI, Koffron A, Yao L, Saggi B, Buell JF. Outcomes of laparoscopic and open resection for neuroendocrine liver metastases. Surgery. 2012; 152(6):1225-1231. https://doi.org/10.1016/j.surg.2012.08.027 PMid:23068086

Lai EC, Fan ST, Lo CM, et al. Anterior approach for difficult major right hepatectomy. World J Surg. 1996; 20:314-317. https://doi.org/10.1007/s002689900050 PMid:8661837

Shaw IM, Rees M, Welsh FK, Bygrave S, John TG. Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable longterm survival. Br J Surg. 2006; 93:457–464. https://doi.org/10.1002/bjs.5323 PMid:16555242

Nordlinger B, Van Cutsem E, Rougier P et al. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer. 2007; 43(14):2037–2045. https://doi.org/10.1016/j.ejca.2007.07.017 PMid:17766104

Poston GJ, Figueras J, Giuliante F, et al. Urgent need for a new staging system in advanced colorectal cancer. J Clin Oncol. 2008; 26:4828–4833. https://doi.org/10.1200/JCO.2008.17.6453 PMid:18711170

Van den Eynde M, Hendlisz A. Treatment of colorectal liver metastases: A review. Rev Recent Clin Trials. 2009; 4:56–62. https://doi.org/10.2174/157488709787047558

Altendorf-Hofmann A, Scheele J. A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am. 2003; 12: 165-192. https://doi.org/10.1016/S1055-3207(02)00091-1

Benjamin IS, Blumgart LH. Occult hepatic metastases in colorectal carcinoma. Br J Surg. 1986; 73:1046. https://doi.org/10.1002/bjs.1800731233

Jatzko G, Wette V, Müller M, Lisborg P, Klimpfinger M, Denk H. Simultaneous resection of colorectal carcinoma and synchronous liver metastases in a district hospital. Int J Colorectal Dis. 1991; 6:111-114. https://doi.org/10.1007/BF00300206 PMid:1875119

Pawlik TM, Choti MA. Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg. 2007; 11: 1057-1077. https://doi.org/10.1007/s11605-006-0061-3 PMid:17530336

Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg. 1995; 19:59–71. https://doi.org/10.1007/BF00316981 PMid:7740812

Chen TW, Chu CM, Yu JC, Chen CJ, Chan DC, Liu YC, et al. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy. Eur J Surg Oncol. 2007; 33:480–487. https://doi.org/10.1016/j.ejso.2006.10.012 PMid:17129701

de Haas RJ, Adam R, Wicherts DA, Azoulay D, Bismuth H, Vibert E, Salloum C, Perdigao F, Benkabbou A, Castaing D. Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases. Br J Surg. 2010; 97: 1279-1289. https://doi.org/10.1002/bjs.7106 PMid:20578183

Masi G, Loupakis F, Pollina L, Vasile E, Cupini S, Ricci S,Brunetti IM, Ferraldeschi R, Naso G, Filipponi F, Pietrabissa A, Goletti O, Baldi G, Fornaro L, Andreuccetti M, Falcone A. Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases. Ann Surg. 2009; 249: 420-425. https://doi.org/10.1097/SLA.0b013e31819a0486 PMid:19247029

Mathur AK, Ghaferi AA, Osborne NH, Pawlik TM, Campbell DA, Englesbe MJ, Welling TH. Body mass index and adverse perioperative outcomes following hepatic resection. J Gastrointest Surg. 2010; 14: 1285-1291. https://doi.org/10.1007/s11605-010-1232-9 PMid:20532666 PMCid:PMC2925640

Cescon M, Vetrone G, Grazi GL, Ramacciato G, Ercolani G, Ravaioli M, Del Gaudio M, Pinna AD. Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years. Ann Surg. 2009; 249: 995-1002. https://doi.org/10.1097/SLA.0b013e3181a63c74 PMid:19474679

Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999; 230:309–18. https://doi.org/10.1097/00000658-199909000-00004 PMid:10493478 PMCid:PMC1420876

McKay A, You I, Bigam D, Lafreniere R, Sutherland F, Ghali W, Dixon E. Impact of surgeon training on outcomes after resective hepatic surgery. Ann Surg Oncol. 2008; 15: 1348-1355. https://doi.org/10.1245/s10434-008-9838-9 PMid:18306973

Yamamoto J, Saiura A, Koga R, et al. Surgical treatment for metastatic malignancies. Nonanatomical resection of liver metastasis: indications and outcomes. Int J Clin Oncol. 2005; 10:97–102. https://doi.org/10.1007/s10147-004-0481-6 PMid:15864694

Yasui K, Shimizu Y. Surgical treatment for metastatic malignancies. Anatomical resection of liver metastasis: indications and outcomes. Int J Clin Oncol. 2005; 10:86–96. https://doi.org/10.1007/s10147-005-0475-z PMid:15864693

Welsh FK, Tekkis PP, O'Rourke T et al. Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: an aid to clinical decisionmaking. Surg Oncol. 2008; 17:3-13. https://doi.org/10.1016/j.suronc.2007.12.003 PMid:18222689

Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg. 2007; 94:274-286. https://doi.org/10.1002/bjs.5719 PMid:17315288

Sarpel U, Bonavia AS, Grucela A, Roayaie S, Schwartz ME, Labow DM. Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis? Ann Surg Oncol. 2009; 16:379-384. https://doi.org/10.1245/s10434-008-0218-2 PMid:19020941

Lalmahomed ZS, Ayez N, van der Pool AE, Verheij J, IJzermans JN, Verhoef C. Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome? World J Surg. 2011; 35:656-61. https://doi.org/10.1007/s00268-010-0890-9 PMid:21161655 PMCid:PMC3032901

Finch RJ, Malik HZ, Hamady ZZ, Al-Mukhtar A, Adair R, Prasad KR, et al. Effect of type of resection on outcome of hepatic resection for colorectal metastases. Br J Surg. 2007; 94:1242-8. https://doi.org/10.1002/bjs.5640 PMid:17657718

Guzzetti E, Pulitanò C, Catena M, Arru M, Ratti F, Finazzi R, Aldrighetti L, Ferla G. Impact of type of liver resection on the outcome of colorectal liver metastases: a case-matched analysis.J Surg Oncol. 2008; 97: 503-507. https://doi.org/10.1002/jso.20979 PMid:18425789

Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002; 236: 397-406; discussion 406-407. https://doi.org/10.1097/00000658-200210000-00001 PMid:12368667 PMCid:PMC1422593

Pawlik TM, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005; 241:715–722, discussion 722–724. https://doi.org/10.1097/01.sla.0000160703.75808.7d PMid:15849507 PMCid:PMC1357126

Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999; 230:309–318, discussion 318–321. https://doi.org/10.1097/00000658-199909000-00004 PMid:10493478 PMCid:PMC1420876

Gayowski, T. J. et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery. 1994; 116:703–710, discussion 710–711. PMid:7940169 PMCid:PMC2967179

Finch RJ, et al. Effect of type of resection on outcome of hepatic resection for colorectal metastases. Br J Surg. 2007; 94:1242–1248. https://doi.org/10.1002/bjs.5640 PMid:17657718

Melendez J, et al. Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg. 2001; 192: 47–53. https://doi.org/10.1016/S1072-7515(00)00745-6

Stewart GD, et al. The extent of resection influences outcome following hepatectomy for colorectal liver metastases. Eur J Surg Oncol. 2004; 30:370–376. https://doi.org/10.1016/j.ejso.2004.01.011 PMid:15063889

Published

2018-06-09

How to Cite

1.
Petrovski S, Karakolevska-Ilova M, Simeonovska-Joveva E, Serafimov A, Adzi-Andov L, Dimitrova V. Influence of the Type and Amount of Liver Resection on the Survival of the Patients with Colorectal Metastases. Open Access Maced J Med Sci [Internet]. 2018 Jun. 9 [cited 2024 Apr. 26];6(6):1046-51. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2018.116

Issue

Section

B - Clinical Sciences

Most read articles by the same author(s)